WealthShield Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,277
Closed -$217K 611
2025
Q4
$217K Buy
2,277
+26
+1% +$2.55K 0.02% 327
2025
Q3
$220K Buy
2,251
+4
+0.2% +$414 0.02% 318
2025
Q2
$241K Buy
2,247
+13
+0.6% +$1.31K 0.03% 297
2025
Q1
$225K Buy
+2,234
New +$225K 0.03% 298
2021
Q3
Sell
-2,039
Closed -$87K 302
2021
Q2
$87K Buy
2,039
+6
+0.3% +$252 0.01% 380
2021
Q1
$79K Buy
+2,033
New +$76.9K 0.01% 374
2020
Q4
Sell
-5,806
Closed -$222K 303
2020
Q3
$222K Buy
+5,806
New +$224K 0.08% 232

Other funds holding BSX

WealthShield Partners's BSX Position: Q1 2026 in Review

WealthShield Partners sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,277 shares — an estimated $217K sold.

WealthShield Partners first reported a position in BSX in Q3 2020 and held it in 7 quarters. The position peaked at $241K in Q2 2025. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • WealthShield Partners reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • WealthShield Partners sold 2,277 Boston Scientific shares in Q1 2026, an estimated $217K.
  • WealthShield Partners first reported a position in Boston Scientific in Q3 2020 and held it in 7 quarters.
  • WealthShield Partners's Boston Scientific position peaked at $241K in Q2 2025.
  • 1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on WealthShield Partners's 13F filing for Q1 2026, filed 1 May 2026.